Citrullination alters immunomodulatory function of LL-37 essential for prevention of endotoxin-induced sepsis.
Citrullination alters immunomodulatory function of LL-37 essential for prevention of endotoxin-induced sepsis.
复制标题
DOI:
10.4049/jimmunol.1303062
复制
发表时间:
2014-06-01
期刊:
影响因子:
--
通讯作者:
Potempa J
中科院分区:
文献类型:
--
作者:
Koziel J;Bryzek D;Sroka A;Maresz K;Glowczyk I;Bielecka E;Kantyka T;Pyrć K;Svoboda P;Pohl J;Potempa J
Cathelicidin LL-37 plays an essential role in innate immunity by killing invading microorganisms and regulating the inflammatory response. These activities depend on the cationic character of the peptide, which is conferred by arginine and lysine residues. At inflammatory foci in vivo, LL-37 is exposed to peptidyl arginine deiminase (PAD), an enzyme released by inflammatory cells. Therefore, we hypothesised that PAD-mediated citrullination of the arginine residues within LL-37 will abrogate its immunomodulatory functions. We found that when citrullinated, LL-37 was at least 40 times less efficient at neutralising the proinflammatory activity of LPS due to a marked decrease in its affinity for endotoxin. Also, the ability of citrullinated LL-37 to quench macrophage responses to LTA and Poly (I:C) signalling via TLR2 and TLR3, respectively, was significantly reduced. Furthermore, in stark contrast to native LL-37, the modified peptide completely lost the ability to prevent morbidity and mortality in a mouse model of D-galactosamine-sensitised endotoxin shock. In fact, administration of citrullinated LL-37 plus endotoxin actually exacerbated sepsis due to the inability of LL-37 to neutralise LPS and the subsequent enhancement of systemic inflammation due to increased serum levels of IL-6. Importantly, serum from septic mice showed increased PAD activity, which strongly correlated with the level of citrullination, indicating that PAD-driven protein modification occurs in vivo. Since LL-37 is a potential treatment for sepsis, its administration should be preceded by a careful analysis to ensure that the citrullinated peptide, is not generated in treated patients.
登录
查看更多内容
影响因子:
4.4
作者:
Kandler, Kerstin;Shaykhiev, Renat;Bals, Robert
通讯作者:
Bals, Robert
影响因子:
6.4
作者:
Niyonsaba, F;Iwabuchi, K;Nagaoka, I
通讯作者:
Nagaoka, I
影响因子:
4.4
作者:
Nijnik, Anastasia;Pistolic, Jelena;Hancock, Robert E. W.
通讯作者:
Hancock, Robert E. W.
影响因子:
4.1
作者:
Oren, Z;Lerman, JC;Shai, Y
通讯作者:
Shai, Y
影响因子:
9.8
作者:
Berkestedt, I.;Nelson, A.;Bodelsson, M.
通讯作者:
Bodelsson, M.